Yoram Vodovotz, PhD

Department of Surgery, University of Pittsburgh, Pittsburgh, PA, 15213, USA; Center for Inflammation and Regenerative Modeling, McGowan Institute for Regenerative Medicine, Pittsburgh, PA, 15219, USA

Research interests: surgery; regenerative medicine; circulating inflammatory mediators; organ dysfunction; trauma and sepsis

Dr. Yoram Vodovotz is currently a Professor of Surgery, Immunology, Computational and Systems Biology, Bioengineering,Clinical and Translational Science, and Communication Science and Disorders at the University of Pittsburgh School of Medicine. His research focus is the biology of inflammation, a process that is both necessary to maintaining health and, paradoxically, central to most if not all diseases that affects both developing and industrialized societies. As the Director of the Center for Inflammation and Regenerative Modeling (CIRM; http://www.mirm.pitt.edu/our-research/centers/center-for-inflammation-and-regeneration-modeling-cirm/) at the McGowan Institute for Regenerative Medicine, he has led an interdisciplinary effort combining computational, experimental, and clinicalstudies aimed at a systems-based understanding of inflammation. He has creatednovel, translational applications of mathematical modeling, including in silico clinical trials, patient-specific predictive models, and culminating in the design of abiohybrid device for patient-specific, self-adaptive control of inflammation. Dr. Vodovotz is a co-founder and current President of the Society for Complex Acute Illness (www.scai-med.org), which is dedicated to applying complex systems and other computational approaches in sepsis, trauma, and related diseases. He is also a co-founder of Immunetrics, Inc. (www.immunetrics.com), a Pittsburgh-based company that is commercializing this mathematical modeling work in the context of the pharmaceutical industry, applying computational models of inflammatory disease in the rational design of therapy for inflammatory diseases. He has published over 260 manuscripts, including two books (with one more due in 2019).

Editorial Board
Terms of Appointment: March 2019 - February 2021